Search Within

William D Travis

  1. "Advanced Practice Providers"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
  3. Review (1)
Groups
  1. Advanced Practice Providers (7)
  2. Department of Medicine (7)
  3. Department of Pathology and Laboratory Medicine (7)
  4. Nursing (6)
  5. Solid Tumor Oncology Division (6)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)

More Groups

People
  1. Lee Krug (5)
  2. Andrei Holodny (4)
  3. Maria Pietanza (4)
  4. Mark Kris (4)
  5. Michelle Ginsberg (4)
  6. Adriana Heguy (3)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2014 (1)
  4. 2012 (2)
  5. 2010 (1)
  6. 2009 (1)
Publications
  1. Cancer Discovery (1)
  2. Cancer Immunology, Immunotherapy (1)
  3. Clinical Cancer Research (1)
  4. Infectious Diseases in Clinical Practice (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Elsevier Ireland Ltd. (1)
  5. Lippincott Williams & Wilkins (1)
  6. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Atypical pathogens presenting with pulmonary consolidations detected by cell-free DNA next-generation sequencing in patients with hematologic malignancies
    Review

    Caldararo, M.; Algazaq, J.; Schmidt, E.; Joanow, A.; Mariano, A.; Predmore, J.; Politikos, I.; Cho, C.; Stein, E. M.; Wen, X.; more...
    Infectious Diseases in Clinical Practice (2022)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
    Journal Article

    Zauderer, M. G.; Drilon, A.; Kadota, K.; Huberman, K.; Sima, C. S.; Bergagnini, I.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; more...
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    Journal Article

    Pietanza, M. C.; Kadota, K.; Huberman, K.; Sima, C. S.; Fiore, J. J.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; Holodny, A. I.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Journal Article

    Krug, L. M.; Dao, T.; Brown, A. B.; Maslak, P.; Travis, W.; Bekele, S.; Korontsvit, T.; Zakhaleva, V.; Wolchok, J.; Yuan, J.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save